Here are eight quick facts:
1. Abbott will sell the test for $5.
2. The test is the size of a credit card, making it very portable and in a familiar format for mass testing through healthcare providers.
3. There is not extra equipment required to conduct the test.
4. The test can provide results in 15 minutes.
5. Abbott launched a complementary mobile app for iPhone and Android called Navica, available at no charge.
6. Mobile app users will be able to access a temporary digital health pass via QR code indicating test results, and the pass will update with each new test. Organizations can use the mobile device information to facilitate entry into events and public spaces.
7. The device has 97.1 percent sensitivity and 98.5 percent specificity in patients with suspected COVID-19 by healthcare providers within the first seven days of symptoms beginning.
8. Abbott plans to ship millions of tests in September and ramp up to 50 million tests per month by October.
More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.